Transition to Adulthood Through Coaching and Empowerment in Rheumatology
TRACER
TRACER: Transition to Adulthood Through Coaching and Empowerment in Rheumatology, A Feasibility Study
1 other identifier
interventional
26
1 country
2
Brief Summary
TRACER is a study aiming to investigate the feasibility of transition coaching sessions for patients moving from paediatric to adult rheumatology care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2022
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 13, 2022
CompletedFirst Posted
Study publicly available on registry
September 19, 2022
CompletedStudy Start
First participant enrolled
October 17, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedFebruary 11, 2026
February 1, 2026
2.5 years
September 13, 2022
February 9, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Consent rate
% of patients approached who consent to the study
19 month recruitment period
Enrolment from non-primary site
% of patients enrolled from non-primary site
19 month
Virtual session attendance
% of transition coaching sessions attended
3 year study period
Outcome measure completion
% of outcome assessments completed at 8 months (end of transition coach invention)
3 year study period
Missing data
% of missing data
3 year study period
Secondary Outcomes (4)
Patient Reported Outcomes Measurement Information System (PROMIS) questionnaire
3 year study period
Physician Global Assessment (PGA)
3 year study period
Active joint count
3 year study period
Global function/quality of life
3 year study period
Study Arms (2)
Standard care - control
NO INTERVENTIONStandard of care, appointments with adult rheumatology
Transition coaching - experimental
EXPERIMENTALParticipants will receive 8 transition coaching sessions (1/month) in addition to standard care
Interventions
Transition coaching sessions (8 sessions), covering paediatric to adult care, self-advocacy, medication management, general health, lifestyle and behaviours, future planning, screening for mood disorders and coping skills.
Eligibility Criteria
You may qualify if:
- Patient with pediatic-onset rheumatic disease
- At their last paediatric rheumatology appointment prior to transferring to adult rheumatology care
- Able to communicate in English
- Have a phone or device capable of participating in video conference
- Available over the next 8 months
You may not qualify if:
- Cognitive impairment preventing participation in individualized education sessions (as determined by medical staff)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- McMaster Universitylead
- Western Universitycollaborator
Study Sites (2)
McMaster Children's Hospital
Hamilton, Ontario, L8N 3Z5, Canada
Children's Hospital at London Health Sciences Centre
London, Ontario, N6A 5W9, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Michelle Batthish, MD
McMaster University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
September 13, 2022
First Posted
September 19, 2022
Study Start
October 17, 2022
Primary Completion
May 1, 2025
Study Completion
December 31, 2025
Last Updated
February 11, 2026
Record last verified: 2026-02